| |
News |
Marketing authorisation of Enkorten in Bosnia and Herzegovina |
| Enkorten is registered in February 2010 in Bosnia and Herzegovina with a registration number 04-07.1-1655-1/09 issued from Drug Agency of Bosnia and Herzegovina. |
WCN 2009 |
| During the World Congress of Neurology (Bangkok, 24-30 October) Farmacija d.o.o. presented the results of phase III clinical study of Enkorten's efficacy in three different abstracts. Read more... |
Safety Profile |
| Safety profile of Enkorten was presented during the III Congress of neurology nurses and techicians in Opatija from 22 to 25 of April 2009. Read more... |
Clinical Phase III |
In December 2008 a complex statistical analysis of clinical phase III results was completed. Read more... |
Presentation of the clinical phase II |
Clinical phase II results of efficacy of Enkorten were presented during the 12 EFNS Congress in Spain in 2008.
Read more... |
| |
|
|
|
| Contact |
| |
|
|
|
|
Farmacija d.o.o. Tuzla
Bajrama Malkočevića 1, 75000 Tuzla, BiH
Tel: +387 35 300 361
Fax: +387 35 250 480
e-mail: info@farmacija.co.ba |
Director
Nedim Zečević, PhD
Tel: +387 35 300 361
e-mail: farmtz@bih.net.ba |
| |
|
Research and Development
Zahida Ademović, PhD
Tel: +387 35 300 364
e-mail: zahida.ademovic@farmacija.co.ba |
Pharmaceutical department
Mersiha Smajlović mr.ph.
Tel: +387 35 300 363
e-mail: m.smajlovic@farmacija.co.ba |
| |
|
Clinical department
Mirela Herljević, PhD
Tel: +387 35 300 363
e-mail: m.herljevic@farmacija.co.ba |
Marketing
Dino Ademović
Tel: +387 35 300 365
Mob: +387 61 894 644
e-mail: d.ademovic@farmacija.co.ba |
| |
|
| Medical diagnostic
Anela Hodžić, dipl.biol.
Tel.: +387 35 300 365
e-mail: a.telalovic@farmacija.co.ba |
|
| |
|
|
|
|
|
